Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dolutegravir”

266 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 266 results

Large-scale testing (Phase 3)Ended earlyNCT03493568
What this trial is testing

Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)

Who this might be right for
HIV-1-infection
IRCCS San Raffaele 100
Not applicableStudy completedNCT05883761
What this trial is testing

Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment

Who this might be right for
Neural Tube DefectsCongenital AbnormalitiesTeratogens
Elizabeth Glaser Pediatric AIDS Foundation 50,075
Post-approval studies (Phase 4)Study completedNCT02519777
What this trial is testing

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 191
Early research (Phase 1)Study completedNCT01498861
What this trial is testing

Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 16
Large-scale testing (Phase 3)Study completedNCT02259127
What this trial is testing

ODYSSEY (PENTA 20)

Who this might be right for
HIV Infection
PENTA Foundation 792
Not applicableLooking for participantsNCT06762054
What this trial is testing

Investigating the Optimal Management of Dolutegravir Resistance

Who this might be right for
HIV-1-infection
University of Nairobi 6,600
Large-scale testing (Phase 3)Looking for participantsNCT06203132
What this trial is testing

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 610
Early research (Phase 1)Study completedNCT02373930
What this trial is testing

Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 63
Large-scale testing (Phase 3)Study completedNCT02777229
What this trial is testing

Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 616
Post-approval studies (Phase 4)Study completedNCT04166474
What this trial is testing

Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

Who this might be right for
HivTuberculosis
Helen Reynolds 36
Very early researchStudy completedNCT05030025
What this trial is testing

Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg)

Who this might be right for
HIV-1-infection
Mylan Inc. 43
Testing effectiveness (Phase 2)Looking for participantsNCT07555431
What this trial is testing

Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

Who this might be right for
HTLV-1 InfectionHTLV I Associated MyelopathiesHTLV I Associated T Cell Leukemia Lymphoma+1 more
Carlos Brites 146
Early research (Phase 1)Study completedNCT01332565
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 10
Not applicableStudy completedNCT04568239
What this trial is testing

Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES)

Who this might be right for
HIV-1-infection
Association de Recherche en Virologie et Dermatologie 712
Not applicableStudy completedNCT03336346
What this trial is testing

Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana

Who this might be right for
Contraceptive UsageHIV InfectionsDrug Interaction
Columbia University 148
Large-scale testing (Phase 3)Study completedNCT03122262
What this trial is testing

ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy

Who this might be right for
HIV-1 Infection
Professor Francois Venter 1,110
Large-scale testing (Phase 3)Study completedNCT04021290
What this trial is testing

Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)

Who this might be right for
HIV Infections
ViiV Healthcare 493
Not applicableUnknownNCT03564613
What this trial is testing

Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women

Who this might be right for
HIV Infections
ViiV Healthcare 250
Large-scale testing (Phase 3)Looking for participantsNCT06497465
What this trial is testing

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Who this might be right for
TuberculosisHIV
Johns Hopkins University 150
Testing effectiveness (Phase 2)Ended earlyNCT04900038
What this trial is testing

A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 85
Load More Results